Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000878088-11-000078)

Filing Details

Accession Number:: 0000878088-11-000078
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-12-19 14:42:00
Reporting Period:: 2011-12-15

Filing Date:: 2011-12-19
Accepted Time:: 2011-12-19 14:42:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
878088	Par Pharmaceutical Companies Inc.	PRX	Pharmaceutical Preparations (2834)	223122182

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189790	M Ronald Nordmann	C/O Par Pharmaceutical Companies Inc. 300 Tice Blvd. Woodcliff Lake NJ 07677		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-12-15	2,500	$29.90	6,500	No	4	M	Direct
Common Stock	Disposition	2011-12-15	200	$32.50	6,300	No	4	S	Direct
Common Stock	Disposition	2011-12-15	2,200	$32.50	4,100	No	4	S	Direct
Common Stock	Disposition	2011-12-15	100	$32.50	4,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock, Option to buy	Disposition	2011-12-15	2,500	$0.00	2,500	$29.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-01-08	2012-01-07	No	4	M	Direct

Footnotes

Mr. Nordmann was granted an option to purchase 2,500 shares of Common Stock under the Company's 1997 Directors Stock and Deferred Fee Plan on January 8, 2002, all of which vested on January 8, 2003. The expiration date of this option is January 7, 2012.